Insilico Medicine

News

AI in drug discovery and development: news watch

Recent developments in the biopharma AI world include a big financing for Verily, and updates from Zealand, Latent Labs, Insilico, and BMS/insitro.

News

AI in drug development news round-up

Recent developments in biopharma AI include an alliance between Thermo and Datavant, plus news from Insilico, Evinova, BPGbio, Evogene, and AMPLY.

News

Insilico Medicine and Servier logos on a black background

Insilico adds Servier to partnership roster with $888m deal

Insilico has added to its partnerships list with an $888m cancer-focused alliance with Servier, just days after completing its long-awaited IPO.

News

Insilico ends 2025 with $293m Hong Kong IPO

One of the pioneers in AI-powered drug discovery, Insilico Medicine, has completed an oversubscribed IPO in Hong Kong, raising around $293m.

News

MSD's $349m alliance with Variational, and other AI news

MSD signs $345m alliance with Variational AI, plus updates on AI in drug discovery projects from Bio Protocol, Dalton Tx, Virginia Tech, and Insilico.

Digital

AI in drug discovery and development: news watch

AI in drug development news round-up

Insilico adds Servier to partnership roster with $888m deal

Insilico ends 2025 with $293m Hong Kong IPO

MSD's $349m alliance with Variational, and other AI news

The AI drug discovery race: Who’s leading the charge?

Novo unveils first data for 'triple G' agonist in diabetes

Using AI-driven synthetic personas to take your insights fur...

Insilico Medicine

Editor's Picks